Atlas Trials

Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma

7 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma

RecordFirmDate
Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies (NCT03272633)Rutgers, The State University of New Jersey2020-10-26
Yttrium Y 90 Basiliximab and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Mature T-cell Non-Hodgkin Lymphoma (NCT02342782)City of Hope Medical Center2020-06-08
Study of Pembrolizumab (MK-3475) in Combination With Romidepsin (NCT03278782)M.D. Anderson Cancer Center2017-11-14
Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma (NCT03011814)City of Hope Medical Center2017-03-08
Alisertib and Romidepsin in Treating Patients With Relapsed or Refractory B-Cell or T-Cell Lymphomas (NCT01897012)National Cancer Institute (NCI)2013-07-17
Ruxolitinib Phosphate to Treat Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma After Stem Cell Transplant (NCT01431209)University of Nebraska2011-08-12
Lenalidomide Therapy After Chemotherapy & Stem Cell Transplant in Treating Chemotherapy Resistan Non-Hodgkin Lymphoma (NCT01035463)University of Nebraska2009-11-12

Track Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.